Justin Klein

About

Justin Klein is a co-founder and Managing Partner at Vensana Capital, a leading venture capital and growth equity firm dedicated to medtech innovation. Justin currently or previously served on the board of directors of Abrus Bio, Apella, Cartiva (acquired), ChromaCode, Cleerly, Curate BioSciences, CV Ingenuity (acquired), Epix Therapeutics (acquired), Evident Vascular, Intact Vascular (acquired), Luna Diabetes, Personal Genome Diagnostics (acquired), PhaseBio Pharmaceuticals (IPO), Relievant Medsystems (acquired), Senseonics (IPO), Topera (acquired), Ulthera (acquired), Ventaris Surgical, Vertiflex (acquired), Vesper Medical (acquired), Volta Medical, and VytronUS (acquired). Justin currently serves as a member of the board of directors of the Medical Device Manufacturers Association and that of AdvaMed Accel, where he is the Chair of the Investor Advisory Committee of AdvaMed's board.

Source (opens in a new tab)